{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:54Z","timestamp":1793640714889,"version":"4.5.1"},"reference-count":18,"publisher":null,"issue":"4","license":[{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/lib.ossn.ru\/jour\/about\/editorialPolicies#openAccessPolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kardiologiia"],"abstract":"<jats:p>\n                    <jats:italic>Aim<\/jats:italic>\n                    . Identification of clinical and instrumental predictors for non-arrhythmic death in patients with heart failure (HF) and implantable cardioverter-defibrillator (ICD).\n                    <jats:italic>Material and methods<\/jats:italic>\n                    . Through a telephone survey and examination of medical records from hospital and polyclinic databases, data were obtained on the alive\/dead status and causes of death for 260 patients with heart failure (HF) and ICD included in the Kuzbass Registry of Patients with ICD. The follow-up period was 1.5 years. Clinical and instrumental parameters entered into the registry before the ICD implantation were included in a univariate and multivariate step-by-step analysis using the logistic (for qualitative variables) and linear (for quantitative variables) regression with calculation of regression coefficients and construction of a prognostic regression model. The quality of the created model was assessed using a ROC analysis.\n                    <jats:italic>Results<\/jats:italic>\n                    . During the observation period, 54 (20.8%) patients died. In 21 (38.8%) patients, death occurred in the hospital and was caused by acute decompensated heart failure in 15 (71.4%) patients, myocardial infarction in 3 (14.3%) patients, stroke in 1 (4.7%) patient, and pneumonia in 2 (9.5%) patients. 33 (61.2%) patients died outside the hospital; the cause of death was stated as the underlying disease associated with acute decompensated heart failure: in 9 (27.2%) patients, dilated cardiomyopathy; in 1 (3.0%) patient, rheumatic mitral disease; and in 23 (69.7%) patients, ischemic cardiomyopathy. According to the univariate regression model, the risk of death in the long-term period was increased by the QT interval prolongation (U 2.41, p = 0.0161); elevated pulmonary artery systolic pressure (U 4.30, p=0.0000) and increased left atrial size according to echocardiography (U 2.98, p=0.0029); stage IIB HF (OR 2.41; 95% CI: 1.26-4.6), NYHA III-IV (OR 3.03; 95% CI: 1.58-5.81); chronic obstructive pulmonary disease (OR 5.24; 95% CI: 2.04-13.45); and lack of optimal drug therapy (ODT) for HF before ICD implantation (OR 2.41; 95% CI: 1.29-4.49). The multivariate analysis identified the most significant factors included in the prognostic regression model: pulmonary artery systolic pressure above 45\u2008mm Hg, social status, chronic obstructive pulmonary disease, and lack of ODT for HF.\n                    <jats:italic>Conclusion<\/jats:italic>\n                    . To ensure a maximum benefit from ICD, the factors that increase the likelihood of non-arrhythmic death should be considered before making a decision on ICD implantation. Particular attention should be paid to mandatory ODT for HF as the main modifiable risk factor for unfavorable prognosis.\n                  <\/jats:p>","DOI":"10.18087\/cardio.2024.4.n2370","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T05:08:46Z","timestamp":1715663326000},"page":"31-37","source":"Crossref","is-referenced-by-count":1,"title":["Predictors of Unfavorable Prognosis in Patients with Heart Failure After Cardioverter-Defibrillator Implantation According to the Prospective Part of the Kuzbass Registry"],"prefix":"10.68900","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-3807","authenticated-orcid":true,"given":"N. B.","family":"Lebedeva","sequence":"first","affiliation":[{"name":"Research Institute for Complex Problems of Cardiovascular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-1158","authenticated-orcid":true,"given":"I. V.","family":"Talibullin","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Problems of Cardiovascular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0019-766X","authenticated-orcid":true,"given":"P. G.","family":"Parfenov","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Problems of Cardiovascular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4642-3610","authenticated-orcid":true,"given":"O. L.","family":"Barbarash","sequence":"additional","affiliation":[{"name":"Research Institute for Complex Problems of Cardiovascular Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":null,"published-online":{"date-parts":[[2024,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Wellens HJJ, Schwartz PJ, Lindemans FW, Buxton AE, Goldberger JJ, Hohnloser SH et al. Risk stratification for sudden cardiac death: current status and challenges for the future. European Heart Journal. 2014;35(25):1642\u201351. DOI: 10.1093\/eurheartj\/ehu176","DOI":"10.1093\/eurheartj\/ehu176"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Borne RT, Varosy PD, Masoudi FA. Implantable Cardioverter-Defibrillator Shocks: Epidemiology, Outcomes, and Therapeutic Approaches. JAMA Internal Medicine. 2013;173(10):859\u201365. DOI: 10.1001\/jamainternmed.2013.428","DOI":"10.1001\/jamainternmed.2013.428"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Boriani G, De Ponti R, Guerra F, Palmisano P, Zanotto G, D\u2019Onofrio A et al. Sinergy between drugs and devices in the fight against sudden cardiac death and heart failure. European Journal of Preventive Cardiology. 2021;28(1):110\u201323. DOI: 10.1093\/eurjpc\/zwaa015","DOI":"10.1093\/eurjpc\/zwaa015"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Rizzello V. Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction. European Heart Journal Supplements. 2022;24(Suppl I):I139\u201342. DOI: 10.1093\/eurheartjsupp\/suac087","DOI":"10.1093\/eurheartjsupp\/suac087"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Looi K-L, Sidhu K, Cooper L, Dawson L, Slipper D, Gavin A et al. Long-term outcomes of heart failure patients who received primary prevention implantable cardioverter-defibrillator: An observational study. Journal of Arrhythmia. 2018;34(1):46\u201354. DOI: 10.1002\/joa3.12027","DOI":"10.1002\/joa3.12027"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Lebedeva N.B., Talibullin I.V., Temnikova T.B., Mamchur S.\u0415., Barbarash O.L. Clinical and anamnestic characteristics of patients with an implanted cardioverter-defibrillator in real clinical practice (data from the Kuzbass register). Kardiologiia. 2021;61(8):40\u20137. DOI: 10.18087\/cardio.2021.8.n1651","DOI":"10.18087\/cardio.2021.8.n1651"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Tereshchenko S.N., Galyavich A.S., Uskach T.M., Ageev F.T., Arutyunov G.P., Begrambekova Yu.L. et al. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):311\u201374. DOI: 10.15829\/1560-4071-2020-4083","DOI":"10.15829\/29\/1560-4071-2020-4083"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Younis A, Goldberger JJ, Kutyifa V, Zareba W, Polonsky B, Klein H et al. Predicted benefit of an implantable cardioverter-defibrillator: the MADIT-ICD benefit score. European Heart Journal. 2021;42(17):1676\u201384. DOI: 10.1093\/eurheartj\/ehaa1057","DOI":"10.1093\/eurheartj\/ehaa1057"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Naksuk N, Akkaya M, Adabag S. Application of the Multicenter Automatic Defibrillator Implantation Trial II Risk Score in a Nontrial Setting. The American Journal of Cardiology. 2013;112(4):530\u20132. DOI: 10.1016\/j.amjcard.2013.04.019","DOI":"10.1016\/j.amjcard.2013.04.019"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Ruwald A-C, Gislason GH, Vinther M, Johansen JB, Nielsen JC, Petersen HH et al. The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers. EP Europace. 2018;20(2):301\u20137. DOI: 10.1093\/europace\/euw408","DOI":"10.1093\/europace\/euw408"},{"key":"ref11","unstructured":"Revishvili A.Sh., Neminushchy N.M., Golitsyn S.P. All-Russian clinical recommendations for controlling the risk of sudden cardiac arrest and sudden cardiac death, prevention and first aid. - M.: GEOTAR-Media;2018. - 256 p. ISBN 978-5-9704-4464-1"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Zac\u00e0 V. Sacubitril\/valsartan or an implantable cardioverter-defibrillator in heart failure with reduced ejection fraction patients: a cost-effectiveness analysis. Journal of Cardiovascular Medicine. 2018;19(10):597\u2013605. DOI: 10.2459\/JCM.0000000000000708","DOI":"10.2459\/JCM.0000000000000708"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Tromp J, Ouwerkerk W, van Veldhuisen DJ, Hillege HL, Richards AM, van der Meer P et al. A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction. JACC: Heart Failure. 2022;10(2):73\u201384. DOI: 10.1016\/j.jchf.2021.09.004","DOI":"10.1016\/j.jchf.2021.09.004"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Ezzat VA, Lee V, Ahsan S, Chow AW, Segal O, Rowland E et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our \u2018real-world\u2019 data an underestimation? Open Heart. 2015;2(1):e000198. DOI: 10.1136\/openhrt-2014-000198","DOI":"10.1136\/openhrt-2014-000198"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Abboud J, St. Josefs-Hospital, Wiesbaden, Germany, Ehrlich JR, St. Josefs-Hospital, Wiesbaden, Germany. Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks. Arrhythmia & Electrophysiology Review. 2016;5(2):117\u201321. DOI: 10.15420\/AER.2016.10.2","DOI":"10.15420\/AER.2016.10.2"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Bae MH, Cho Y, Hwang J, Park H-S, Han S, Lee YS et al. Clinical Impact of Implantable Cardioverter-Defibrillator Therapy and Mortality Prediction Model for Effective Primary Prevention in Korean Patients. Journal of Korean Medical Science. 2020;35(9):e49. DOI: 10.3346\/jkms.2020.35.e49","DOI":"10.3346\/jkms.2020.35.e49"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Priori SG, Blomstr\u00f6m-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal. 2015;36(41):2793\u2013867. DOI: 10.1093\/eurheartj\/ehv316","DOI":"10.1093\/eurheartj\/ehv316"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Polyakov D.S., Fomin I.V., Belenkov Yu.N., Mareev V.Yu., Ageev F.T., Artemjeva E.G. et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4\u201314. DOI: 10.18087\/cardio.2021.4.n1628","DOI":"10.18087\/cardio.2021.4.n1628"}],"container-title":["Kardiologiia"],"original-title":[],"link":[{"URL":"https:\/\/lib.ossn.ru\/jour\/article\/viewFile\/2370\/1551","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:16:38Z","timestamp":1793639798000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardio.elpub.ru\/jour\/article\/view\/2370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,30]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,30]]}},"URL":"https:\/\/doi.org\/10.18087\/cardio.2024.4.n2370","relation":{},"ISSN":["2412-5660","0022-9040"],"issn-type":[{"value":"2412-5660","type":"electronic"},{"value":"0022-9040","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,30]]}}}